English
往期目录
新闻公告
More
化学进展 2005, Vol. 17 Issue (05): 916-923 前一篇   后一篇

• 综述与评论 •

L-核苷类抗HIV、HBV活性化合物研究进展

董春红1;常俊标1,2*   

  1. 1.中国科学技术大学化学系 合肥 230027；

    2.河南省科学研究中心 郑州 450002

  • 收稿日期:2003-11-01 修回日期:2004-11-01 出版日期:2005-09-24 发布日期:2005-09-24
  • 通讯作者: 常俊标
下载PDF ( 1637 ) 引用
导出 被引次数 ( 30 | 2 )

Advances in L-Nucleosides as Anti-HIV and Anti-HBV Agents

Dong Chunhong1;Chang Junbiao1,2*   

  1. 1.Department of Chemistry, University of Science and Technology of China,Hefei 230027,China;

    2.The Research Center of Henan Academy of Sciences, Zhengzhou 450002,China

  • Received:2003-11-01 Revised:2004-11-01 Online:2005-09-24 Published:2005-09-24
  • Contact: Chang Junbiao
抗病毒新试剂的不断涌现,为HIV、HBV感染者的临床治疗提供了有效的方法.在抗病毒试剂中,核苷类化合物占据了十分重要的地位.本文阐述了核苷类化合物抗病毒的作用机理,介绍了L型核苷的发展历史及一些新型具有抗HIV、HBV生物活性的L型核苷类化合物的分类.同时,通过对一些新型具有抗HIV、HBV生物活性的核苷类化合物如BCH、FTC、OddC、d4A、Fd4C等,D型和L型不同对映异构体抗病毒活性及生物毒性的对比发现,L型异构体比其相应的D型异构体具有抗病毒活性更高、生物毒性更低的特点.药物化学家们对此产生了极大的兴趣,进一步开展了新型L型核苷类化合物设计、合成的相关研究,以便筛选出更安全有效的抗病毒试剂.
关键词： L-核苷, 抗HIV活性, 抗HBV活性
Drug discovery for anti-HIV, anti-HBV chemotherapy has provided the effective clinical treatment. Among these antiviral agents used in therapy, nucleoside analogues are particularly useful. In this paper, the antiviral mechanism of the nucleoside analogues, the discovery of L-nucleoside and the classificalion of some new anti-HIV, anti-HBV L-nucleoside analogues are introduced. In addition, the datum of two enantiomers of some anti-HIV, anti-HBV nucleoside analogues indicate that the bioactivities and securities of L-nucleoside analogues is superior to the counterpart enantiorners. As a result, the medicinal chemists have focused their attention on designing and preparing new L-nucleoside analogues to search for more powerful and securer new antiviral agents.
Key words: L-nucleosides, anti-HIV, anti-HBV

中图分类号: 

()

[ 1 ] Levene P A , Jacobs W A. Chem. Ber. , 1909 , 42 : 2474 —2478
[ 2 ] De Clerq E. Adv. Drug Res. , 1988 , 17 : 1
[ 3 ] Chu C K, Baker D C. Nucleosides and Nucleotides as Antitumor Agents and Antiviral Agents. New York : Plenum Press , 1993
[ 4 ] De Clerq E. J . Med. Chem. , 1995 , 38 : 2491 —2517
[ 5 ] Gumina G, Chong Y, Song G Y, Chu C K. Current Topics in Medicinal Chemistry , 2002 , 2 : 1065 —1086
[ 6 ] Lin T S , Luo M Z , Liu M C. Tetrahedron Lett . , 1994 , 35 : 3477
[ 7 ] Chu C K, Ahn S K, Kim H O , et al . Tetrahedron Lett . , 1991 ,32 : 3791
[ 8 ] Kim H O , Schinazi R F , Shanmuganathan K, et al . J . Med.Chem. , 1993 , 36 : 519
[ 9 ] Bolon P , Wang P , Chu C K, et al . Bioorg. Med. Chem. Lett . ,1996 , 6 : 1657
[10] Chang C N , Dong S L , Zhou J H , et al . J . Biol . Chem. , 1992 ,267 :13938 —13942
[11] Dong S L , Tsai C H , Schinszi R F. Proc. Natl . Acad. Sci .USA , 1991 , 8495 —8499
[12] Dienstag J L , Perrillo R P , Schiff E R , et al . New Engl . J .Med. , 1995 , 333 : 1657
[13] Chen S H , Lin S , King I , et al . Bioorg. Med. Chem. Lett . ,1998 , 8 : 3245 —3250
[14] Belleau B , Dixit D , Nguyen- Ga N , et al . International Conference on AIDS. Montreal , 1990
[15] Coates J A V , Cammack N , Jenkinson H J , et al . Antimicrob.Agent Chemother. , 1992 , 36 : 202 —205
[16] Schinazi R F , Chu C K, Peck A , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 672 —676
[17] Wang P , Hong J H , Chu C K. Antiviral Res. , 1998 , 40 : 19 —44
[18] Gumina G, Song G Y, Chu C K. FEMS Microb. Lett . , 2001 ,202 : 9 —15
[19] Soudeyns H , Yao Q , Belleau B , et al . Antimicrob. Agent Chemother. , 1991 , 35 : 1386 —1390
[20] Dong S L , Tsai C H , Schinazi R F , et al . Proc. Natl . Acad.Sci . USA , 1991 , 88 : 8495
[21] Coates J A V , Cammack N , Jenkinson H J , et al . Antimicrob.Agent Chemother. , 1992 , 36 : 202 —205
[22] Beach J W, Jeong L S , Alves A J , et al . J . Org. Chem. , 1992 ,57 : 2217 —2219
[23] Chu C K, Beach J W, Jeong L S , et al . J . Org. Chem. , 1991 ,56 : 6503 —6505
[24] Boucher C A , Cammack N , Schipper P , et al . Antimicrob. Agent Chemother. , 1993 , 37 : 2231 —2234
[25] Jeong L S , Schinazi R F , Beach J W, et al . J . Med. Chem. ,1993 , 36 : 181 —195
[26] Parker W B , Cheng Y C. J . NIH Res. , 1994 , 6 : 57 —61
[27] Dienstag J L , Perrillo R P , Schiff E R , et al . New Engl . J .Med. , 1995 , 333 : 1657 —1661
[28] Severini A , Liu X Y, Wilson J S , Tyrrell D L. Antimicrob. Agent Chemother. , 1995 , 39 : 1430 —1435
[29] Schewach D S , Liotta D C , Schinazi R F. Biochem. Pharmcol . ,1993 , 45 : 1540 —1543
[30] Cammack N C , Rouse P L , Marr C L P , et al . Biochem.Pharmcol . , 1992 , 43 : 2059 —2064
[31] Furman P A , Wilson J E , Reardon J E , et al . Antiviral Chem.Chemother. , 1995 , 6 : 345 —355
[32] Schinazi R F , McMillan A , Cannon D , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 2423 —2431
[33] Sommadossi J P , Schinazi R F , Chu C K, et al . Biochem.Pharmcol . , 1992 , 44 : 1921 —1925
[34] Furman P A , Davis M, Liotta D C , et al . Antimicrob. Agent Chemother. , 1992 , 36 : 2686 —2692
[35] Cui L , Schinazi R F , Gosselin G, et al . Biochem. Pharmcol . ,1996 , 52 : 1577 —1584
[36] Norbeck D W, Spanton S. Tetrahedron Lett . , 1989 , 30 : 6263 —6266
[37] Kim H O , Shanmuganathan K, Alves A J , et al . Tetrahedron Lett . , 1992 , 33 : 6899 —6902
[38] Grove KL , Guo X, Liu S H , et al . Cancer Res. , 1995 , 55 :3008 —3011
[39] Schinazi R F , McClure H M, Boudinout F D , et al . Antiviral Res. , 1994 , 23(suppl) : 81
[40] Rajagopalan P F , Boudinot F D , Chu C K, et al . Pharm. Res. ,1994 , 11( suppl) : 381
[41] Van Draannen N A , Tisadle M, Parry N R , et al . Antimicrob.Agent Chemother. , 1994 , 38 : 868 —871
[42] Faraj A , Agrofoglio L A , Wakefield J K, et al . Antimicrob.Agent Chemother. , 1994 , 38 : 2300 —2305
[43] Chong Y, Chu C K. Carbonhydr. Res. , 2002 , 337 : 397 —402
[44] Bridges B , Juodawikis A , Faraj A , et al . Antimicrob. Agents Chemother. , 2001 , 45 : 229 —235
[45] Lin Y S , Luo M Z , Liu M C , et al . J . Med. Chem. , 1996 , 39 :1757 —1759
[46] Bolon J P , Wang P Y, Chu C K, et al . Bioorg. Med. Chem.Lett . , 1996 , 6 (14) : 1657 —1662
[47] Fourel I , Hantz O , Watanabe K A , et al . Antimicro. Agents Chemother. , 1990 , 34 : 473 —475
[48] Fried M W, Dibisceglie A M, Straus S E , et al . Hepatology ,1992 , 16 : 127A
[49] Peek S F , Cote P J , Jacob J R , et al . Hepatology , 2001 , 33 :254 —266
[50] Gumina G, Song G Y, Chu C K. Antiviral Chem. Chemother. ,2001 , 12 : 89 —112
[51] Zhu Y, Yamamoto T , Cullen J , et al . J . Virol . , 2001 , 75 :311 —322
[52] Ma T W, Pai S B , Zhu YL , et al . J . Med. Chem. , 1996 , 39 :2835 —2843
[53] Ma T W, Lin J C , Newton M G, et al . J . Med. Chem. , 1997 ,40 : 2750 —2754
[54] Mellors J , Lederman M, Haas D , et al . Abstracts of 5th Conference on Retroviruses and Opportunistic Infections. Chicago ,1998
[55] Wang P Y, Schinazj R F , Chu C K. J . Med. Chem. , 1999 , 42 :3390 —3399
[56] Lee K, Chol Y, Gullen E , et al . J . Med. Chem. , 1999 , 42 :1320 —1328
[57] Pai S B , Litto D C , Chu C K, et al . Abstracts of Papers 3rd International Conference on Therapies for Viral Hepatitis. USA ,1999
[58] Pai S B , Chu C K, Litto D C , et al . Antiviral Ther. , 2000 , 5(suppl . 1) : B66
[59] Jin D Z , Kwon S H , Moon H R , et al . Bioorg. Med. Chem. ,2004 , 12 : 1101 —1109
[60] KimJ , Hong J H. Carbohydrate Res. , 2003 , 338 : 705 —710
[61] Aragonès S , Bravo F , Diaz Y, et al . Tetrahedron Lett . , 2003 ,44 : 3771 —3773
[62] Lee K, Chol Y, Gumina G, et al . J . Med. Chem. , 2002 , 45 :1313 —1320
[63] Choi Y, Choo H , Chong Y, et al . Org. Lett . , 2002 , 4 : 305 —307
[64] Pejanovic V , Stokic Z , Stojanovic B , et al . Bioorg. Med.Chem. , 2003 , 1849 —1852
[65] Chong Y, Gumina G, Chu C K. J . Med. Chem. , 2003 , 46 :3245 —3256
[66] Ugarkar B G, Castellino A G, DaRe J S , et al . J . Med. Chem. ,2003 , 46 : 4750 —4760
[67] Gumina G, Schinazi R F , Chu C K. Org. Lett . , 2002 , 4 :4177 —4180
[68] Verri A , Priori G, Spadari S , et al . Biochem. J . , 1997 , 328 :317 —320
[69] Seley K L , Stewart M G, Cheng Y C , et al . Nucleosides Nucleotides , 1999 , 18 : 807 —810
No related articles found!